Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome

scientific article published on 23 March 2007

Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1365-2265.2007.02807.X
P698PubMed publication ID17381484

P2093author name stringLars Wilhelmsen
Marie-Louise Barrenäs
Charles Hanson
Christina Larsson
Inger Bryman
Kerstin Landin-Wilhelmsen
Mostafa El-Mansoury
P2860cites workTurner's syndrome in adulthoodQ34114075
Delayed diagnoses of Turner's syndrome: proposed guidelines for change.Q34511441
Turner's syndrome in dermatologyQ35751189
New issues in the diagnosis and management of Turner syndromeQ36324342
Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical featuresQ40550174
Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapyQ40787666
Reference values for body proportions and body composition in adult women with Ullrich-Turner syndrome.Q40874549
Ear and hearing in relation to genotype and growth in Turner syndrome.Q50496086
Risk factors for cardiovascular disease during the period 1985-1995 in Göteborg, Sweden. The GOT-MONICA Project.Q50927432
Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome.Q55067592
Epidemiological, endocrine and metabolic features in Turner syndromeQ57632192
Morbidity in Turner SyndromeQ57632257
P433issue5
P304page(s)744-751
P577publication date2007-03-23
P1433published inClinical EndocrinologyQ15762781
P1476titleChromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome
P478volume66